주식/증권
📈 긍정적
관련 뉴스
Nxera Pharma GAAP EPS of ¥15.86, revenue of ¥18.91B; reaffirms FY 2026 outlook
2026/08/07
Relmada plans NDV-01 IND by end of 2026 as cash runway extends through 2029
2026/08/07
State Bank of India reports Q1 results
2026/08/07
Here's the 1 Habit That Has Helped Ordinary Investors Build Extraordinary Wealth in the Stock Market
2026/08/07